BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2016
View Archived Issues
Researchers present promising data for the novel Mdm2 inhibitor NVP-HDM201
Read More
Arbaclofen ER compared to baclofen in multiple sclerosis patients with spasticity
Read More
GlaxoSmithKline and Anacor Pharmaceuticals exploit novel mechanism for treating tuberculosis
Read More
SAR-428926, a novel ADC with promising activity in preclinical models of cancer
Read More
Pneumococcal infection model reveals protective effects of B-cell epitopes
Read More
Bayer Schering Pharma patents CDK inhibitors
Read More
Merck & Co. discloses ROMK blockers
Read More
Positive results reported from two phase III studies of SUN-101/eFlow for COPD
Read More
X-Chem achieves milestone in Alexion collaboration
Read More
Janssen Pharmaceutica describes FFAR1 agonists
Read More
Adimab enters two new antibody collaborations
Read More
Protagonist Therapeutics presents LPAM-1 receptor antagonists
Read More
Positive results from phase II study of AZP-531 in Prader-Willi Syndrome
Read More
First patient randomized in the dalGenE phase III cardiovascular outcomes trial
Read More
Cosmo Technologies reports AR and GR antagonists
Read More
Cumberland Pharmaceuticals commences new systemic sclerosis program for ifetroban
Read More
Sanofi enters collaborations to predict diabetes medication adherence
Read More
Grant supports University of Manchester's research in frontotemporal lobar degeneration
Read More
FDA extends PDUFA date for Heplisav-B BLA
Read More
Biosortia announces new oncology research projects
Read More
Sanofi makes proposal to acquire Medivation
Read More
Clinical trial investigates gene therapy for Batten disease CLN6
Read More
First patient dosed in phase I trial of Agenus' AGEN-1884
Read More
Shionogi reports promising phase II data for Japanese Cedar pollen sublingual immunotherapy tablet
Read More
E.U. approval for TachoSil for use in neurological surgery
Read More
Lonsurf approved in Europe
Read More
FDA accepts OPKO's resubmitted NDA for calcifediol
Read More
AbGenomics reports final results from phase II trial of neihulizumab in psoriatic arthritis
Read More